These final results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 help the idea of targeting ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Conditions. A study research posted https://bonom803cdv2.loginblogin.com/profile